Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial
Article in BioDrugs (March 2023)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in BioDrugs (March 2023)
Article in Advances in Radiation Oncology (July 2022)